InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: greenswing post# 19065

Wednesday, 04/05/2017 12:49:38 PM

Wednesday, April 05, 2017 12:49:38 PM

Post# of 74170
Otiko has to buy the right to use the Phillips/Keough trans-dermal delivery system referenced in my Stickie/iBox. At this time, he only has shown a non-exclusive license to manufacture and distribute the Diabecline clone Viabecline. Phillips has confirmed this agreement.

When the business is centered around a trans-dermal delivery system there are numerous avenues for growth.